Pharma Pulse 7/3/24: What to Know About New and Future ALZ Drugs, Bridging the Gap Between Innovation and Implementation & more

Analyzing the Effects of Respiratory Syncytial Virus Pre- and Post-Pandemic

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.

Bridging the Gap Between Innovation and Implementation in Healthcare Today

The speed of adoption of new practices in medicine is extremely slow. We need systems to test new protocols, make sure they’re safe and effective, and get them out into the world more rapidly.

Enhance Early Protocol Design with Evidence-Driven Insights

Scarcity of data and siloed data sources lead to gaps in information that create challenges in study design. Additionally, the increase in trial complexity, which has seen a 600% increase in collected data points, contributes to a negative impact on a variety of trial performance outcomes. Evidence-based insights help study teams iterate upon ideas that can lead to lean study designs, resulting in reduced data points, decreased costs, and less deviations.

This webinar uncovers how technology and analytics can be applied to address key areas during study design/synopsis development. Learn how design analytics can help sponsors make early, in-flight design decisions prior to protocol authoring, such as selecting best endpoints, determining which eligibility criteria will improve probability of success, and identifying key regulatory design considerations.

Alzheimer’s Disease Treatments: What to Know About New and Future Drugs

Newly approved Kisunla promises to slow the disease, but patients will have to consider risks and reimbursement.

Walgreens Strengthens Support for Children and Adults Living with Diabetes

The retail pharmacy chain will highlight a variety of offerings and healthcare solutions for managing diabetes at Friends for Life Conference hosted by Children with Diabetes.

Penny Paul on LinkedIn

Check out Lowenstein Sandler LLP FDA Regulatory Chair Jim Shehan’s two-part video interview with Pharmaceutical Executive where he breaks down the top legal and regulatory concerns for investors in GLP-1 drugs and why doing your homework is crucial in this crowded market.

#lawyers #lifesciences #regulatorycompliance #fda #pharmaindustry

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs